Drag resistant M. tuberculosis among tuberculosis patients in prisons Source: Eur Respir J 2001; 18: Suppl. 33, 313s Year: 2001
Mycobacterium tuberculosis drug resistance surveillance in BelarusSource: Eur Respir J 2005; 26: Suppl. 49, 199s Year: 2005
Structure of M. tuberculosis drug resistance in penitentiary institutions of Belarus Source: Eur Respir J 2006; 28: Suppl. 50, 586s Year: 2006
Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008
Drug resistance trends and patterns of mycobacterium tuberculosis isolates from pulmonary tuberculosis patients at a tertiary care hospital in Turkey Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012
High incidence of the Beijing strains among multi drug resistance isolates of Mycobacterium tuberculosis from extra pulmonary tuberculosis cases in northern India Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012
Molecular surveillance of multi-drug resistant tuberculosis in Europe Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007
Clinical and genotypic pattern of multidrug resistant tuberculosis isolated from extrapulmonary tuberculosis cases in tertiary care hospitals in northern India Source: Annual Congress 2011 - Challenges in tuberculosis control Year: 2011
Multidrug resistant tuberculosis (MDR – TB) treatment outcomes in Iran Source: Eur Respir J 2004; 24: Suppl. 48, 657s Year: 2004
Multi-drug resistant pulmonary tuberculosis in Belarus Source: Annual Congress 2007 - Epidemiology of various lung diseases Year: 2007
Side effects observed in process of multidrug resistant tuberculosis management in tomsk oblast penitentiary system Source: Eur Respir J 2001; 18: Suppl. 33, 313s Year: 2001
Molecular epidemiology of multi drug resistance tuberculosis isolates from pulmonary tuberculosis cases from Lucknow, India Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012
Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia) Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
Frequency of rifampicin resistance in re-treatment cases of pulmonary tuberculosis using Gene-Xpert in a tertiary care hospital tuberculosis clinic Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015
Primary drug resistance against mycobacterium tuberculosis in a high burden country Source: Eur Respir J 2006; 28: Suppl. 50, 587s Year: 2006
Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015
Spread of tuberculosis among household contacts of multi drug resistant tuberculosis (MDRTB) patients Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014
XDR and MDR-TB genetic markers of M. tuberculosis strains circulating in Kyrgyz Republic Source: Annual Congress 2011 - Challenges in tuberculosis control Year: 2011
Multidrug resistance influence on tuberculosis mortality and lethal outcome in prisons of Belarus Source: Eur Respir J 2007; 30: Suppl. 51, 425s Year: 2007